AVESTHAGEN LIMITED
Tucker McGaw has a diverse work experience spanning several industries. Tucker currently serves as the Director at Oakum Chartered since April 2021. Previously, Tucker held the position of Managing Director at sonaCAD starting from December 2018. Tucker also worked as the Global Head of Technology & Director at Written Medicine from November 2012. Tucker has experience in creative direction and editing as the Creative Director & Editor-in-Chief at ThatMate, where they focused on sexual education for rural Indian children, starting from October 2016. Additionally, Tucker has been involved in the Avestagenome Project as an Advisory Board member and Senior Manager in Technical Operations. Tucker has worked at Avesta Good Earth Foods in various roles, including Head of Global Marketing & Virtual CIO. Tucker also served as the Virtual CIO & Operations Manager at Avesthagen and as a Senior Strategy Consultant at Ava Seeds. In their most recent roles, they were Chief Commercial Officer at Intrepid Cycles and Strategic Advisor at Ad Documentum.
Tucker McGaw completed their high school education at Ocean View High School from 1999 to 2001, earning a High School Diploma in Business/Corporate Communications. Following this, they attended Plymouth State University from 2003 to 2007, where they obtained a Bachelor of Science degree in IT and Business Administration.
In addition to their formal education, Tucker McGaw has obtained several certifications. In 2010, they acquired the Fire Marshal certification from St John Ambulance. In 2015, they gained certifications in various areas such as Certified Functional Site Owner (FSO), Anti-Bribery At Risk, Conflicts of Interest, Effective Trade Compliance, Group Records Management, Safeguarding Information Mandate, and Certification of Completion - Overview of Upstream Business, all from Shell. In the same year, they also became a First Aider certified by SOS. Furthermore, in 2019, they received a Certificate of Recognition from InterNations.
AVESTHAGEN LIMITED
Avesthagen Limited - Brief Summary Avesthagen is a leading systems biology life science company uniquely positioned to help solve some of the world’s biggest healthcare and environmental challenges. Since its inception 20 years ago, Avesthagen has introduced new ideas, technologies, and products, for the life sciences market. The Avestagenome Project® is Avesthagen’s largest epidemiological study ever conducted in India, and the first such detailed system biology study worldwide on an endogamous population. The project has collected a biobank of Parsi blood samples with extensive patient data from 4,500 members and investigates the molecular basis of longevity and age-related disorders, prioritizing cancers, cardiovascular disease, diabetes and neurological disorders. Recognizing the importance of the Parsi cohort and the unique systems’ biology approach to research, the U.S.-based Foundation for a Smoke-Free World, whose mission is to end smoking within this generation, recently awarded a grant to Avesthagen Limited® to prioritize research into lung and tobacco-related cancers. Avesthagen will combine liquid biopsy, next-generation sequencing (NGS), state- of-the-art bioinformatics, artificial intelligence and machine learning to identify predictive and early-stage biomarkers of cancers in smokers. The project will use non-Parsi smoker and non-smoker samples from the wider Indian and other populations to gain further insights into the evidence behind such data. Avesthagen is expected to be a key player in the lucrative personalised medicine market, which is projected to reach a value of US $1.7 trillion by 2026. Today, Avesthagen is proud to build on this heritage by partnering with others to tackle unprecedented challenges now facing our world. We believe we can provide enough healthy food for people everywhere and protect the environment for generations to come.